Antiviral cyclic D,L-alpha-peptides: targeting a general biochemical pathway in virus infections.
about
Insights into Adenovirus Uncoating from Interactions with Integrins and Mediators of Host ImmunityInhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cellsA direct and versatile assay measuring membrane penetration of adenovirus in single cells.Cyclopeptides containing the DEKS motif as conformationally restricted collagen telopeptide analogues: synthesis and conformational analysis.Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides.Self-assembling peptide nanotubes with antiviral activity against hepatitis C virusNovel approaches to flavivirus drug discovery.AdenovirusEfficient route to C2 symmetric heterocyclic backbone modified cyclic peptidesPeptide antimicrobial agents.Probing peptide nanotube self-assembly at a liquid-liquid interface with coarse-grained molecular dynamicsTowards functional bionanomaterials based on self-assembling cyclic peptide nanotubes.Self-assembling viral mimetics: one long journey with short steps.De novo designed peptides for biological applications.Therapeutic approaches using host defence peptides to tackle herpes virus infections.Design and properties of functional nanotubes from the self-assembly of cyclic peptide templates.Something between the amazing functions and various morphologies of self-assembling peptides materials in the medical field.Serine/threonine ligation for natural cyclic peptide syntheses.Peptide nanostructures in biomedical technology.Transmembrane delivery of anticancer drugs through self-assembly of cyclic peptide nanotubes.A combinatorial approach to the discovery of biocidal six-residue cyclic D,L-alpha-peptides against the bacteria methicillin-resistant Staphylococcus aureus (MRSA) and E. coli and the biofouling algae Ulva linza and Navicula perminuta.Self-Assembling Cyclic d,l-α-Peptides as Modulators of Plasma HDL Function. A Supramolecular Approach toward Antiatherosclerotic Agents.GeT peptides: a single-domain approach to gene delivery.Self-Assembled Cyclic d,l-α-Peptides as Generic Conformational Inhibitors of the α-Synuclein Aggregation and Toxicity: In Vitro and Mechanistic Studies.Antimicrobial peptides
P2860
Q28078297-86716BF5-BE6F-4786-A8CC-70C175EECFF7Q30357092-63DE5CF0-91EA-4626-A5AC-6B46845D25A7Q30413406-84981EB6-D31D-4F58-B5AA-92AC01D3988FQ30878012-FC6905F2-517C-42E0-BB4E-C40988510A61Q33496543-04CD97C5-5711-4128-AD7D-770F49CFE690Q34084050-F419AB1A-5692-487E-AEED-0164ADB38A3BQ34206832-ED8F91FE-4CBD-4EEE-97D7-E89638311436Q34977219-BB223710-5E02-4FE9-9E10-41DD407D2A56Q35691246-3B31B67A-AB93-41A5-AB5D-90734DA0BF36Q36538861-5AEA96EA-7DB5-445B-9E9C-35A610C0562CQ37227296-B192C127-0779-48DC-824F-EE270B34E65BQ37737076-0B657B10-C32B-4C5A-8DF5-0F1024E674D0Q37821835-BE62DB10-41D3-49F7-B0F3-BD603076D3FBQ37849603-16927E27-757D-40B3-AB7C-4B6726E8EC47Q37945181-FAF0F825-FCB8-4703-9909-8691CFF1C908Q38033032-A0F61B54-F9A1-48DB-AEA7-ABE8E047082CQ38236567-56E0829E-FCB0-44D4-9747-ECE9A3CA5131Q38507318-86C098C6-8679-4D87-9101-81241DFF29BAQ38723306-F948272D-C039-46FF-86B9-ADF44BAD2C33Q38787285-AC7F0143-0679-4615-81DB-10B6EAC48B80Q39923401-76B691E4-614D-44DE-8C63-84222C001543Q40993177-D9FDC004-7D0E-4191-99BB-59E8BB5C1746Q45020310-2DCCB757-51FE-4A54-8358-BE8D241C0D0AQ46500132-87E4DE09-F532-4069-93AD-8B0E13C1C3A1Q55982720-764E16F1-0C4C-411E-B42B-B9BBD2A333C8
P2860
Antiviral cyclic D,L-alpha-peptides: targeting a general biochemical pathway in virus infections.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Antiviral cyclic D,L-alpha-pep ...... l pathway in virus infections.
@ast
Antiviral cyclic D,L-alpha-pep ...... l pathway in virus infections.
@en
type
label
Antiviral cyclic D,L-alpha-pep ...... l pathway in virus infections.
@ast
Antiviral cyclic D,L-alpha-pep ...... l pathway in virus infections.
@en
prefLabel
Antiviral cyclic D,L-alpha-pep ...... l pathway in virus infections.
@ast
Antiviral cyclic D,L-alpha-pep ...... l pathway in virus infections.
@en
P2093
P2860
P1476
Antiviral cyclic D,L-alpha-pep ...... al pathway in virus infections
@en
P2093
Christopher M Wiethoff
Chunli Cui
Glen R Nemerow
Keith M Wilcoxen
M Reza Ghadiri
W Seth Horne
P2860
P304
P356
10.1016/J.BMC.2005.05.051
P407
P577
2005-09-01T00:00:00Z